Concepedia

Medora M. Hardy

MM

10

Publications

1.1K

Citations

10

H-Index

1997

Active since

Affiliations

Pfizer (United States)(Current)

Monsanto (United States)

Washington University in St. Louis

Medora M. Hardy is an author at Pfizer (United States) specializing in medicine, drug discovery, and cell biology.

Top concepts

Publications per year

1997–2010

10

Publications

10

Reactive Nitrogen Intermediates Promote Low Density Lipoprotein Oxidation in Human Atherosclerotic Intima

Christiaan Leeuwenburgh, Medora M. Hardy, Stanley L. Hazen et al. · Journal of Biological Chemistry · 1997 · 462 citations · Full text

Cyclooxygenase 2‐dependent prostaglandin E<sub>2</sub> modulates cartilage proteoglycan degradation in human osteoarthritis explants

Medora M. Hardy, Karen Seibert, Pamela T. Manning et al. · Arthritis & Rheumatism · 2002 · 301 citations

Epidermal COX-2 Induction Following Ultraviolet Irradiation: Suggested Mechanism for the Role of COX-2 Inhibition in Photoprotection

Catherine S. Tripp, Eric A.G. Blomme, K Chinn et al. · Journal of Investigative Dermatology · 2003 · 151 citations · Full text

, , +9

Pharmacology of PF-4191834, a Novel, Selective Non-Redox 5-Lipoxygenase Inhibitor Effective in Inflammation and Pain

Jaime L. Masferrer, Ben S. Zweifel, Medora M. Hardy et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 48 citations

Novel Insights into the Cellular Mechanisms of the Anti-inflammatory Effects of NF-κB Essential Modulator Binding Domain Peptides

Eric T. Baima, Julia A. Guzova, Sumathy Mathialagan et al. · Journal of Biological Chemistry · 2010 · 40 citations · Full text

Rows per page

1–5 of 10